title: Counterpoint: should epidermal growth factor receptor mutations be routinely tested for in patients with lung cancer? No.
authors: Department of Medicine, University of Hong Kong, Hong Kong, SAR, China. Electronic address: Chinadcllam@hku.hk.
authors: David C L
authors: DCL
authors: Lam
mesh_terms: D000230:Adenocarcinoma / Q000188:drug therapy / Q000235:genetics; D004252:DNA Mutational Analysis; D003955:Diagnostic Tests, Routine; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy / Q000235:genetics*; D009154:Mutation; D047428:Protein Kinase Inhibitors / Q000627:therapeutic use; D011505:Protein-Tyrosine Kinases / Q000037:antagonists & inhibitors
chemical_list: D047428:Protein Kinase Inhibitors; D011505:Protein-Tyrosine Kinases